VR Logo

Penumbra Inc. (PEN) download report


Healthcare | Medical Devices & Equipment

Penumbra Inc. (PEN) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally.

IPO Date: 18-Sep-2015

Co-Founder, Chairman, Pres & CEO: Mr. Adam Elsesser

Co-Founder & Director: Dr. Arani Bose M.D.

Listing: NYSE: PEN

Country: United States

Headquarters: Alameda, CA

Website: https://www.penumbrainc.com

Key Facts

Market cap: $4,736.07 Mln

Revenue (TTM): $782.28 Mln

Earnings (TTM): $-6.47 Mln

Cash: $240.34 Mln

Total Debt: $218.99 Mln

Insider's Holding: 4.43%

Liquidity: Low

52 Week range: $114.87 - 293.20

Shares outstanding: 37,677,600

10 Years Aggregate:

  • CFO: $-0.46 Mln
  • EBITDA: $74.29 Mln
  • Net Profit: $74.78 Mln

Stock Performance

Time Period Penumbra (PEN) S&P BSE Sensex* S&P Small-Cap 600*
YTD-56.25-8.62-18.78
1 month-15.85-4.54-8.00
3 months-43.41-10.19-13.65
1 Year-54.131.43-17.19
3 Years-7.7310.146.10
5 Years7.4511.265.87
10 Years--11.829.84
As on 01-Jul-2022 *As on 04-Jul-2022
Year Penumbra (PEN) S&P Small-Cap 600 S&P BSE Sensex
202164.1825.2721.99
20206.539.5715.75
201934.4320.8614.38
201829.68-9.705.87
201747.4911.7327.91
201618.5724.741.95